Get the Stockscreener App
90.75
0.60%
0.54
After Hours:
90.25
-0.50
-0.55%
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific stock holds rating after Axonics acquisition - Investing.com
Boston Scientific expanding again in Maple Grove - The Business Journals
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Nasdaq
Boston Scientific to acquire Intera Oncology, terms not disclosed - Yahoo Finance
Boston Scientific EVP Arthur Butcher sells $1.25 million in stock By Investing.com - Investing.com South Africa
Boston Scientific EVP Arthur Butcher sells $1.25 million in stock - Investing.com
Boston Scientific's SWOT analysis: medtech leader's stock poised for growth - Investing.com
Boston Scientific expands infusion offerings with Intera Oncology acquisition - Medical Device Network
Boston Scientific to acquire Intera Oncology - Investing.com
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc. - Quantisnow
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment - Yahoo Finance
Artificial Organs Market is Expected to Develop at a Stellar 7.68% CAGR through 2031 | SkyQuest Technology - GlobeNewswire Inc.
Electrophysiology Market Top PlayersAbbott, Medtronic, - openPR
Analysts Set Boston Scientific Co. (NYSE:BSX) Target Price at $93.39 - MarketBeat
Boston Scientific Co. (NYSE:BSX) Director Edward J. Ludwig Sells 4,877 Shares - MarketBeat
Boston Sci. Completes $3.7B Axonics Buy - Orange County Business Journal
Boston Scientific director sells $446,901 in stock - Investing.com India
Boston Scientific director sells $446,901 in stock By Investing.com - Investing.com South Africa
Boston Scientific (BSX) Announces 2025 Compensation Plans - GuruFocus.com
Insider Sell: Edward Ludwig Sells Shares of Boston Scientific Co - GuruFocus.com
Boston Scientific sets 2025 bonus, performance plans - Investing.com
Boston Scientific Launches 2025 Incentive Programs - TipRanks
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report? - Yahoo Finance
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Boston Scientific (FRA:BSX) 3-Year Revenue Growth Rate : 11.60% (As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) Purchase Of Investment : €0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) 5-Year EBITDA Growth Rate : 7.40% (As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) Total Inventories : €2,480 Mil (As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) Net-Net Working Capital : €-7.10 (As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) EBIT : €2,281 Mil (TTM As of Sep. 2024) - GuruFocus.com
Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Stake Boosted by PNC Financial Services Group Inc. - MarketBeat
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - Yahoo Finance
Boston Scientific Corp (BSX) Shares Up 3.98% on Nov 19 - GuruFocus.com
Boston Sci study shows Watchman Flx better OPTION than DOAC - BioWorld Online
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific reiterates Buy stock rating on Option study - Investing.com
Boston Scientific stock soars to all-time high of $89.33 - Investing.com
Boston Scientific stock soars to all-time high of $89.33 By Investing.com - Investing.com Canada
Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today - Yahoo Finance
Boston Scientific’s Watchman could be new option for patients post ablation: study - Yahoo Finance
Boston Scientific reports outcomes from trial of LAAC device - Medical Device Network
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific to Acquire Cortex - Today's Medical Developments
Boston Scientific's WATCHMAN FLX Shows Superior Bleeding Risk Reduction in 3-Year Study | BSX Stock News - StockTitan
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific put volume heavy and directionally bearish - TipRanks
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific Closes Acquisition of Axonics, Inc. - Quantisnow
Boston Scientific Closes Acquisition of Axonics, Inc. – Company Announcement - Financial Times
Boston Scientific closes $3.7B Axonics deal after lengthy review - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Boston Scientific Co. (NYSE:BSX) Shares Bought by Huntington National Bank - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 113% gain - Yahoo Finance
Boston Scientific EVP John Sorenson sells $2.68m in stock - Investing.com
Boston Sci charges ahead with AVANT GUARD PFA trial - BioWorld Online
Boston Scientific To Present At 2024 UBS Global Healthcare Conference; Webcast At 10:15 AM ET - Nasdaq
0.40%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):